Cerebral thrombosis
Cerebral thrombosis (CT) is the most common type of cerebral infarction. It is caused by atherosclerosis of the main trunk or cortical branches of the cerebral arteries, which leads to vascular thickening, lumen stenosis and occlusion, and thrombosis, resulting in reduced blood flow or interruption of blood supply to the local brain, ischemia and hypoxia of brain tissue, leading to softening and necrosis, and the appearance of focal neurological symptoms and signs. Therefore, it is also called "atherosclerotic cerebral thrombosis" or "thrombotic cerebral infarction" in clinical practice.
-
Site of disease:
Brain -
Infectious :
Not contagious -
Frequent population:
The incidence rate in middle-aged and elderly men is higher than that in women -
Related symptoms:
Weakness Difficulty swallowing Hypersensitivity Sensory impairment Slow response -
Concurrent disease:
Related Drugs
Ligustrazine Hydrochloride and Glucose Injection
Indication: Used for occlusive cerebrovascular diseases such as cerebral ischemia, cerebral thrombosis, cerebral embolism and other ischemic vascular diseases such as coronary heart disease, vasculitis, etc.
Ligustrazine Hydrochloride and Glucose Injection
Indication: Used for occlusive cerebrovascular diseases such as cerebral ischemia, cerebral thrombosis, cerebral embolism and other ischemic vascular diseases such as coronary heart disease, vasculitis, etc.
Manufacturer:
Echo Group Jiangxi Dongya Pharmaceutical Co., Ltd.
Ligustrazine Hydrochloride and Glucose Injection
Indication: Used for occlusive cerebrovascular diseases such as cerebral ischemia, cerebral thrombosis, cerebral embolism and other ischemic vascular diseases such as coronary heart disease, vasculitis, etc.
Manufacturer:
Echo Group Jiangxi Dongya Pharmaceutical Co., Ltd.
Ligustrazine Hydrochloride and Glucose Injection
Indication: Used for occlusive cerebrovascular diseases such as cerebral ischemia, cerebral thrombosis, cerebral embolism and other ischemic vascular diseases such as coronary heart disease, vasculitis, etc.
Manufacturer:
Sichuan Guorui Pharmaceutical Co., Ltd.
Ligustrazine Phosphate and Sodium Chloride Injection
Indication: Used for ischemic cerebrovascular diseases, such as cerebral ischemia, cerebral thrombosis, and cerebral infarction.
Manufacturer:
Henan Tianfang Huazhong Pharmaceutical Co., Ltd.
Xingnao Zaizao Pills
Manufacturer:
Anshan Pharmaceutical Co., Ltd.
Xingnao Zaizao Pills
Manufacturer:
Liaoning Xiancaotang Pharmaceutical Co., Ltd.
Related Ingredients